India to Kenya: Ustekinumab Export Trade Route

The India to Kenya Ustekinumab corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $9.7K USD. The route is dominated by ALLEVIARE LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ustekinumab manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $1.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (65%) and air (15%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during July–September, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 21.6%, placing it at rank #6 among India's top ustekinumab export destinations globally.

On the import side, key buyers of Indian ustekinumab in Kenya include MXRX ONE STOP PHARMACY PEPONI. MXRX ONE STOP PHARMACY PEPONI is the single largest importer with 8 shipments valued at $9.7K USD.

India's ustekinumab exports to Kenya are driven primarily by a handful of large-scale manufacturers. ALLEVIARE LIFE SCIENCES PRIVATE LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ALLEVIARE LIFE SCIENCES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $1.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical product each pre filled syringe of 1 ml contains 90mg of ustekinumab solution stelara 90mg injection and pharmaceutical product each pre-filled syringe of ustekinumab 90 mg per 1 ml forinjection stelara 90 mg injection pack, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MXRX ONE STOP PHARMACY PEPONI is the largest importer with 8 shipments worth $9.7K USD — representing 100% of all ustekinumab imports from India on this route.